Stocksigma LogoStocksigma Logo

Advanced Enzyme Technologies Reports Q2 FY27 Results with 14% PAT Growth

Advanced Enzyme Technologies reported a 16% YoY increase in consolidated revenue to ₹2,145 million for Q2 FY27 (up 12% QoQ)

Advanced Enzyme Technologies Reports Q2 FY27 Results with 14% PAT Growth

Advanced Enzyme Technologies Ltd · Press Release · 31 Oct 2026, 9:10 pm

Advanced Enzyme Technologies Reports Q2 FY27 Results with 14% PAT Growth Advanced Enzyme Technologies reported a 16% YoY increase in consolidated revenue to ₹2,145 million for Q2 FY27 (up 12% QoQ). EBITDA rose 20% YoY to ₹721 million, expanding margins to 34% from 33% in Q2 FY26. Consolidated PAT grew 14% YoY to ₹512 million, maintaining a 24% net margin with EPS at ₹4.33. Revenue expansion was led by Bio-Processing (up 43% YoY to ₹365 million) and Animal Nutrition (up 37% YoY to ₹265 million). Domestic revenue increased 25% YoY to ₹1,110 million, contributing 52% of total sales.

Original exchange filing (PDF)

More announcements from Advanced Enzyme Technologies Ltd

All Advanced Enzyme Technologies Ltd announcements